Literature DB >> 12127402

Loss of heterozygosity at pseudoautosomal regions in human breast cancer and association with negative hormonal phenotype.

Laura Roncuzzi1, Irene Brognara, Stefania Cocchi, Wainer Zoli, Anna Gasperi-Campani.   

Abstract

To determine the possible involvement of X-linked genes in breast cancer, a group of human sporadic breast carcinomas were analyzed for loss of heterozygosity (LOH) at 12 polymorphic loci distributed along the whole chromosome X. LOH by at least one marker was observed in 14 of 46 informative cases and two regions of consistent LOH in 10 of 14 (71.4%) were identified at pseudoautosomal regions (PAR). Allelic losses in these regions significantly correlated with the absence of estrogen receptors (P<0.05) and concordant absence of either estrogen (ER) or progesterone (PgR) receptors (P<0.05). The clinicopathological parameters evaluated, (like age, menopausal status, histological type, tumor size, nodal status, grading, ploidy, labeling index, and S-phase fraction), were independent from the LOH present in the PAR regions of X chromosome. This study suggests a role as a prognostic factor for LOH and ER(-)/PgR(-) when associated and provides some additional support for the existence of candidate tumor suppressor gene on PAR regions, whose alteration may play a role in breast cancer development and progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12127402     DOI: 10.1016/s0165-4608(01)00652-5

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

1.  Characterization of ductal carcinoma in situ cell lines established from breast tumor of a Singapore Chinese patient.

Authors:  Jacklyn Wy Yong; Meng Ling Choong; SiFang Wang; Yu Wang; Shermaine Qy Lim; May Ann Lee
Journal:  Cancer Cell Int       Date:  2014-09-20       Impact factor: 5.722

2.  FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene.

Authors:  Tao Zuo; Lizhong Wang; Carl Morrison; Xing Chang; Huiming Zhang; Weiquan Li; Yan Liu; Yin Wang; Xingluo Liu; Michael W Y Chan; Jin-Qing Liu; Richard Love; Chang-Gong Liu; Virginia Godfrey; Rulong Shen; Tim H-M Huang; Tianyu Yang; Bae Keun Park; Cun-Yu Wang; Pan Zheng; Yang Liu
Journal:  Cell       Date:  2007-06-14       Impact factor: 41.582

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.